NewsRoom Articles - Page 1374 of 1436

ThursdayDec 15, 2016 9:43 am

How to play the Dow 20K

Since the Dow is within spitting distance of breaking the 20,000 point level, for the first time, let’s look at what the pros are thinking. Jim Suva, Citi Research Analyst, forecast a "Tax reform benefit from reduction in corporate taxes and cash repatriation," as Citi Research reiterated its buy rating on Apple (NASDAQ: AAPL), while CNBC’s Jim Cramer added that IBM (NYSE: IBM) "would be a huge beneficiary of Trump's proposed lower corporate tax rates. It is a terrific play on a stronger economy.” So, it’s looking like the experts think that the Dow stalwarts are going to benefit from…

ThursdayDec 15, 2016 9:11 am

Hope for HIV Patients as CytoDyn Inc. (CYDY) Therapy Proves Efficacy during Clinical Trials

PRO 140, an innovative new therapy for HIV patients developed by CytoDyn Inc. (OTCQB: CYDY), is currently undergoing Phase 3 clinical trials, having been administered to several patients, according to a company press release (http://nnw.fm/a8eyJ). No other details were provided about the initial results of Phase 3 trials, but a separate report said actor Charlie Sheen is one of the subjects and that he has achieved undetectable viral load after taking PRO 140. Sheen, who revealed his HIV status in November last year, has been a part of the study for eight months and is receiving weekly injections of the…

WednesdayDec 14, 2016 3:41 pm

As Social Reality (NASDAQ: SRAX) Completes “Pivotal Year” New White Paper Suggests Trend in Programmatic Growth

Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company that has developed SRAX, a real-time bidding (RTB) management platform that, among other capabilities, increases the efficiency with which online publishers are able to capitalize on programmatic advertising auctions. In November, a new whitepaper (http://nnw.fm/m3LAi) sponsored by Xaxis, in conjunction with IDC, expanded upon the notion that programmatic technology is rapidly spreading and redefining the way many brands are approaching advertising. Based on the whitepaper’s findings, nearly $15 billion was spent on brand campaigns based on automated platforms during 2015, with IDC estimating in excess of $100 billion in spending…

WednesdayDec 14, 2016 3:06 pm

Moxian, Inc. (NASDAQ: MOXC) Embraces New Media for Interactive Marketing

Moxian, Inc. (NASDAQ: MOXC), a top digital marketing company, uses powerful social media-driven marketing and sales tools to connect online users and merchants. Backed by a flourishing online-to-offline integrated platform, this company offers offline merchants solid opportunities to strengthen their outreach to digital consumers. Since it was founded in 2013, Moxian has catered to one particular business pain: the merchant’s need to engage with more digitally-savvy consumers. Along the way, this offline-to-online integrated platform operator has expanded from managing its operations from its base in Shenzhen, China, to creating branch offices in Beijing, Malaysia and Hong Kong. Following the Nasdaq…

WednesdayDec 14, 2016 1:16 pm

Singlepoint, Inc. (SING) Maintaining a Positive Outlook on the Future of Marijuana Sales Processing

Despite California still looking to Trump to address marijuana industry banking challenges, Singlepoint, Inc. (OTC: SING) is maintaining a positive outlook on the future of marijuana sales processing in the state. An article by Above the Law (http://nnw.fm/1D0hL) suggests that California may be able to secure bank accounts relating to cannabis businesses as long as the FinCEN cannabis banking guidelines from 2014 hold up and certain enterprising financial institutions become more willing to experiment. As a result of the passing of Proposition 64, many are confident that some of California’s financial institutions will be taking advantage of FinCEN’s 2014 guidelines…

WednesdayDec 14, 2016 12:09 pm

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Ready for New Challenges on Health Insurance Market as Fate of Obamacare Uncertain

One of the biggest questions after President-elect Donald Trump is officially sworn in is what will happen with the controversial Affordable Care Act, also known as Obamacare – a law intended to make health insurance more affordable for medium and low-income Americans. Trump himself has often pledged to repeal and replace the law when he takes office, while his pick for Secretary of Health, Georgia Rep. Tom Price is a fierce opponent of the plan and sponsored a reconciliation bill last year designed to cut funding for the program. The bill, which was passed by both houses of Congress but…

WednesdayDec 14, 2016 10:26 am

SenesTech, Inc. (SNES) is “One to Watch”

With the recent EPA approval (http://nnw.fm/X82tJ) of SenesTech’s (NASDAQ: SNES) ContraPest®, a humane, liquid contraceptive bait designed to address unwieldy rodent populations, there now appears to be an impending end to the unsustainable rodenticide paradigm that has persisted for decades due to a lack of other options. SenesTech is Arizona’s newest public company, as of its December 8 IPO (http://nnw.fm/m4xhG) on the NASDAQ Capital Market. The publicly traded stock gives investors a big opportunity to get in on the ground floor behind a proprietary and potentially paradigm-shattering technology that is not only safe to humans, but also drastically less impactful…

WednesdayDec 14, 2016 9:13 am

eXp World Holdings, Inc. (EXPI) Maintaining a Positive Outlook for the Real Estate Industry in the U.S.

eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for the agent-owned cloud-brokerage eXp Realty LLC, is maintaining a positive attitude toward the coming year. Most recently, RISMedia (http://nnw.fm/l7zcS) published a study highlighting the fact that more real estate executives are confident about their own local economies than about the world economy. Yet many real estate executives are concerned about risks posed by rising costs for traditional real estate, especially if the market should slump. eXp World Holdings, Inc. is of the same opinion, pointing out that expenditures on brick and mortar facilities would remain fixed in the face of…

TuesdayDec 13, 2016 1:40 pm

Two FDA Clearances in Less Than a Month Have Top Analysts Watching Xtant Medical (XTNT)

Investors and financial analysis firms have taken note of two paramount FDA approvals for Xtant Medical (NYSE: XTNT) within less than a month’s time. The supplier of spine surgery and orthopedic products announced on November 17 that it won FDA clearance for its Irix-C cervical cage, as covered by a recent article (http://nnw.fm/Omu1Z). Xtant Medical stated that the product was previously only cleared for use with autogenous bone graft, but is now cleared for use with autografts or allografts, as well as an expanded range of levels allowable (now from C3-T1 to C2-T1). This news was immediately followed by the…

TuesdayDec 13, 2016 12:12 pm

AppNexus IPO may signal bright outlook for the Ad Tech space

With the Wall Street Journal (http://nnw.fm/9SxEJ) reporting that AppNexus filed its IPO paperwork, in a deal that is likely to be underwritten by Goldman Sachs (NYSE: GS) and JP Morgan Chase (NYSE: JPM), it’s time to review the ad tech landscape. After all, the deal is projected to be twice as large as the most recent ad tech IPO, The Trade Desk (NASDAQ: TTD), which commanded a premium of nearly 80% above its IPO price target and a $1 billion opening trading day valuation. Despite the sagging economy, internet and mobile advertising has been growing by approximately 20% per year. …

Financial news and publishing for public and private companies

Contact us: 512.354.7000